Disc Medicine, Inc. (IRON)

NASDAQ: IRON · USD

$83.2

+3.28 (+4.1%)· Recorded snapshot

Market cap	3.7B
Net income (ttm)	-245.9M
EPS (ttm)	-$6.56
Shares out	44.4M
Volume	637,888
Beta	2.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -245.9M
EPS (ttm): -$6.56
Market cap: 3.7B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ถือ

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-39.1

P25 -113.8P50 -46.5P75 -0.9

ROIC-24.9

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All IRON indicators

Market & fundamental data

Available fields

177

Groups with data

Currency

USD

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001816736
Company name	Disc Medicine, Inc.
Country	United States
Country code	US
CUSIP number	254604101
Earnings date	2026-11-09
Earnings time	bmo
Employees	165
Employees change	40
Employees growth	32%
Enterprise value	$3B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2017
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US2546041011
Last 10-K release date	2026-02-26
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$3.7B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$83.18
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	IRON
U.S. state	Massachusetts
Website	https://www.discmedicine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7.88%
FCF / EV yield	-6.66%
FCF yield	-5.46%
Forward EV/Sales	3,557.64x
Forward P/S	4,345.9x
P/B ratio	4.76x
Price / tangible book value	5.62x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.5M
ROA	-23.96%
ROA (5Y)	-22.78%
ROCE	-38.09%
ROE	-39.08%
ROE (5Y)	-40.2%
ROIC	-24.85%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	1
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-46,000
Depreciation and amortization	$355,000
EBIT	$-268.4M
EBITDA	$-268.1M
EPS	$-6.56
FCF per share	$-4.45
Financing cash flow	$262.3M
Free cash flow	$-197.6M
Free cash flow minus SBC	$-243M
Income taxes	$310,000
Investing cash flow	$-93.4M
Net borrowing	$30M
Net cash flow	$-28.7M
Net income	$-245.9M
Operating cash flow minus SBC	$-243M
Operating income	$-268.4M
Stock-based compensation	$45.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$16.80
Debt / equity	0.09
Interest coverage	-75.57
Long-term assets	$2.3M
Long-term liabilities	$60.5M
Net cash (debt)	$656.9M
Net cash / market cap	18.14%
Net cash growth	6.11%
Net debt / equity	-1.02
Piotroski F-Score	1
Property, plant and equipment	$1.8M
Shareholders' equity	$644.2M
Tangible book value	$644.2M
Tangible book value per share	$16.80
Total assets	$735.1M
Total cash	$717.7M
Total debt	$60.9M
Total liabilities	$90.9M
WACC	15.67%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$732.8M
Current liabilities	$30.4M
Current ratio	24.14
Net working capital	$-15M
Quick ratio	23.64
Working capital	$702.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-16.89%
Dividend yield	0%
Shareholder yield	-16.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$71.27
1D price change	4.11%
1M price change	26.49%
1M total return	26.49%
1W price change	3.83%
1W total return	3.83%
1Y price change	-7.95%
1Y return CAGR	-7.96%
1Y total return	-7.95%
20-day SMA	$67.37
200-day SMA	$70.62
3M price change	10.6%
3M total return	10.6%
3Y price change	89.92%
3Y return CAGR	23.83%
3Y total return	89.92%
50-day SMA	$71.26
50-day SMA vs 200-day SMA	50over200
52-week high	$99.50
52-week high date	2025-12-08
52-week low	$40.00
52-week low date	2026-02-13
6M price change	19.86%
6M total return	19.86%
All-time high	$99.50
All-time high date	2025-12-08
All-time low	$15.00
All-time low date	2022-12-30
Average true range (ATR)	$4.13
Average volume	1.5M
Beta (1Y)	1.25
Beta (2Y)	1.66
Beta (5Y)	2.11
Change from 52-week high	-16.4%
Change from 52-week low	107.95%
Change from all-time high	-17.07%
Change from all-time low	450.13%
Change from open	4.27%
Day's gap	-0.16%
Dollar volume	$53.1M
High price	$83.54
Low price	$79.59
Monthly RSI	60.42
Open price	$79.77
Position in 52-week range	90.89%
Premarket change	-0.09%
Premarket close	$79.90
Premarket price	$79.83
Previous close	$79.90
Price vs 150-day SMA	15.78%
Price vs 20-day SMA	22.48%
Price vs 200-day SMA	16.84%
Price vs 50-day SMA	15.8%
Relative volume	0.42
RSI	69.32
Sharpe ratio	0.1
Sharpe ratio (3Y)	0.62
Sortino ratio	0.27
Sortino ratio (3Y)	1
Volume	637.9K
Weekly RSI	60.4
YTD price change	3.92%
YTD total return	3.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39M
Float percentage	87.82%
Shares change (QoQ)	0.5%
Shares change (YoY)	16.89%
Shares held by insiders	0.49%
Shares held by institutions	95.07%
Shares outstanding	44.4M
Short % of float	18.65%
Short % of shares	16.38%
Short ratio	12.7 days

Deeper analysis on IRON

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this IRON report

Is a complete IRON research report available?

No complete published report is available for Disc Medicine, Inc. (IRON) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Disc Medicine, Inc. (IRON)

Price

Financial snapshot

Fair-value bridge

Latest news · IRON

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All IRON indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on IRON

Frequently asked questions